openPR Logo
Press release

Arthritis Monoclonal Antibodies Market Size, Trends, Growth, Outlook 2024-2033

Arthritis Monoclonal Antibodies Market

Arthritis Monoclonal Antibodies Market

"The new report published by The Business Research Company, titled ""Arthritis Monoclonal Antibodies Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the arthritis monoclonal antibodies market size has grown strongly in recent years. It will grow from $58.09 billion in 2023 to $62.29 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The arthritis monoclonal antibodies market size is expected to see strongly grown in the next few years. It will grow to $83.76 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3449&type=smp

Arthritis Prevalence Fuels Growth In Arthritis Monoclonal Antibody Market
The increasing prevalence of arthritis globally has contributed to the growth of the arthritis monoclonal antibody market. According to the Global RA Network, in 2021, Over 350 million individuals worldwide suffer from arthritis and osteoarthritis is the most common form of arthritis followed by gout, fibromyalgia, and rheumatoid arthritis. According to WHO, the prevalence of rheumatoid arthritis varies between 0.3% and 1%, and the worldwide estimates of osteoarthritis include 9.6% of men and 18% of women. The increased prevalence of arthritis and the demand for personalized medicine are increasing the demand for the market.

Advancements In Therapeutic Monoclonal Antibodies Revolutionize The Arthritis Treatment Landscape
The development of therapeutic monoclonal antibody products is becoming an indispensable tool in the development of the arthritis monoclonal antibody market. Monoclonal antibodies are more efficient than small molecules and peptides in the treatment of arthritis. These are target-specific and have good efficiency for disease treatment. These improved treatment options are evident with the launch of a greater number of monoclonal antibody drugs for arthritis.

The arthritis monoclonal antibodies market covered in this report is segmented -

1) By Drug: Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima
2) By Application: Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Other Applications
3) By End-Use: Hopitals, Research Institutes, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=3449&type=discount

Major companies operating in the arthritis monoclonal antibodies market include Johnson & Johnson, Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., AbbVie Inc., Amgen Inc., Genentech Inc., GlaxoSmithKline plc., AstraZeneca plc, Mylan N.V., Bristol Myers Squibb, Eli Lilly and Company, Thermo Fisher Scientific Inc., Sanofi SA, Novo Nordisk A/S, Daiichi Sankyo Company Ltd., Seattle Genetics, Teva Pharmaceutical Industries Ltd., Shanghai Junshi Biosciences Co. Ltd., GenScript Biotech Corporation, Sigma-Aldrich Co. LLC, AbGenomics Corp., ADC Therapeutics SA, Agensys Inc., Alexion Pharmaceuticals Inc., ALMAC Group Ltd., Ambrx Inc., Astellas Pharma Inc., Celgene Corporation, Celldex Therapeutics Inc., Boehringer Ingelheim International GmbH, Celltrion Inc., HanAll Biopharma Co. Ltd., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation, Regeneron Pharmaceuticals Inc., Samsung Bioepis Co. Ltd.

Contents of the report:
1. Executive Summary
2. Arthritis Monoclonal Antibodies Market Report Structure
3. Arthritis Monoclonal Antibodies Market Trends And Strategies
4. Arthritis Monoclonal Antibodies Market - Macro Economic Scenario
5. Arthritis Monoclonal Antibodies Market Size And Growth
…..
27. Arthritis Monoclonal Antibodies Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Arthritis Monoclonal Antibodies Market Size, Trends, Growth, Outlook 2024-2033 here

News-ID: 3594200 • Views:

More Releases from The Business research company

Top Trends Transforming the Fluoropolymer Films Market Landscape in 2025: Technological advancements are a popular trend in the fluoropolymer films market. Major companies operating in the fluoropolymer films market are focused on new technological innova
Top Trends Transforming the Fluoropolymer Films Market Landscape in 2025: Techno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Fluoropolymer Films Industry Market Size Be by 2025? The fluoropolymer films market has seen strong growth recently. It will expand from $2.5 billion in 2024 to $2.65 billion in 2025 at a CAGR of 5.7%. Growth drivers in the past included high thermal stability, electronics manufacturing
Driving Digitally Printed Wallpaper Market Growth in 2025: The Role of Rising Urbanization Drives Growth In Digitally Printed Wallpaper Market
Driving Digitally Printed Wallpaper Market Growth in 2025: The Role of Rising Ur …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Digitally Printed Wallpaper Market Size Growth Forecast: What to Expect by 2025? The digitally printed wallpaper market has expanded rapidly in recent years. It will grow from $9.13 billion in 2024 to $10.26 billion in 2025, at a CAGR of 12.4%. Historic growth was fueled by interior design preferences,
Top Market Shifts Transforming the Biodegradable Paper and Plastic Packaging Market Landscape: Key Insights
Top Market Shifts Transforming the Biodegradable Paper and Plastic Packaging Mar …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Biodegradable Paper and Plastic Packaging Market Through 2025? Over the past few years, we've witnessed a significant expansion in the size of the biodegradable paper and plastic packaging market. It is projected to rise from $12.97 billion in 2024 to $14.12 billion
Acrylic Rubber Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth
Acrylic Rubber Market Landscape to 2034: Key Forces Shaping the Next Decade of G …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Acrylic Rubber Market Size By 2025? The acrylic rubber industry has seen robust growth in the past few years. The market value, which is projected to escalate from $1.63 billion in 2024 to $1.74 billion in 2025, implies a compound annual growth rate (CAGR) of

All 5 Releases


More Releases for Arthritis

Rising Arthritis Cases Fueling Market Growth For Rheumatoid Arthritis Drugs: Piv …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Rheumatoid Arthritis Drugs Market Size Growth Forecast: What to Expect by 2025? In recent years, there has been a slight decline in the rheumatoid arthritis drugs market size. It is projected to rise from "$60.3 billion in 2024 to $60.1 billion in 2025, with a compound annual growth rate
Infectious Arthritis (Septic Arthritis) Market Detailed Industry Report Analysis …
Introduction Infectious arthritis, also known as septic arthritis, is a serious joint condition caused by bacterial, viral, or fungal infections that lead to rapid joint destruction if not treated promptly. The disease primarily affects large joints such as the knee and hip but can also impact smaller joints. It is considered a medical emergency requiring rapid diagnosis and treatment with antibiotics or antifungals, often combined with joint drainage or surgical intervention. The
Nooro Arthritis Hand Massager Reviews: Is the Nooro Arthritis Hand Massager Wort …
The Nooro Arthritis Hand Massager is a revolutionary device designed to offer relief to individuals suffering from hand pain, particularly those dealing with conditions such as arthritis, carpal tunnel syndrome, and repetitive strain injuries. As hand pain can significantly impact daily activities, from typing to gripping objects, finding an effective, non-invasive solution is crucial. The Nooro Arthritis Hand Massager provides a gentle yet effective remedy by combining advanced heat therapy
Rheumatoid Arthritis Drug Market Rheumatoid Arthritis Clinical Pipeline Report 2 …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Antirheumatoids: Call of Rheumatoid Arthritis 1.1 Prologue towards Rheumatoid Arthritis 1.2 Obtainable Treatment for Rheumatoid Arthritis Molecular Mechanism of Antirheumatoids 2.1 Purpose of DMARDs in Rheumatoid Arthritis 2.2 Role of Biological Agents in Rheumatoid Arthritis 2.2.1 TNF- Inhibitors 2.2.2 Interleukin -1 and IL-6 Blockers Classification of Rheumatoid Arthritis Drugs 3.1
Rheumatoid Arthritis Treatment Market
Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheumatoid arthritis needs to be addressed early to avoid expensive joint replacement surgery. While it can affect any joint, small joints in hand and feet tend to be affected the
Worldwide Arthritis - EpiCast Report: Rheumatoid Arthritis - Epidemiology Foreca …
"EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2025" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- ** Summary Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the bodys immune system attacks the lining of the joints, known as